Glauco-Visken

• Vasodilator Agents
• Antihypertensive Agents
• Adrenergic beta-Antagonists
• Serotonin Antagonists
• ATC:C07AA03
• ATC:C07AA14
• ATC:C07AA17

• Betapindol
• Blockin L
• Blocklin L
• Calvisken
• Cardilate
• Decreten
• Durapindol
• Glauco-Visken
• Pectobloc
• Pinbetol
• Prinodolol
• Pynastin
• Visken

• Viskazide 10/25tab (Hydrochlorothiazide + Pindolol)
• Viskazide 10/50tab (Hydrochlorothiazide + Pindolol)

C₁₄H₂₀N₂O₂

http://www.rxlist.com/cgi/generic3/pindolol.htm

Glauco-Visken MSDS

No information avaliable

248.321 g/mol

167-171 ^oC

7880 mg/L

Solid

2.525

Tablet

For the management of hypertension, edema, ventricular tachycardias, and atrial fibrillation.

Pindolol is a non-selective beta-adrenergic antagonist (beta-blocker) which possesses intrinsic sympathomimetic activity (ISA) in therapeutic dosage ranges but does not possess quinidine-like membrane stabilizing activity. Pindolol impairs AV node conduction and decreases sinus rate and may also increase plasma triglycerides and decrease HDL-cholesterol levels. Pindolol is nonpolar and hydrophobic, with low to moderate lipid solubility. Pindolol has little to no intrinsic sympathomimetic activity and, unlike some other beta-adrenergic blocking agents, pindolol has little direct myocardial depressant activity and does not have an anesthetic-like membrane-stabilizing action.

Rapidly and reproducibly absorbed (bioavailability greater than 95%).

LD₅₀=263 mg/kg (orally in rats). Signs of overdose include excessive bradycardia, cardiac failure, hypotension, and bronchospasm.

Humans and other mammals